Calder Biosciences
Business Services · New York, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
140 58th St Ste 8J, Brooklyn, New York, ...Phone Number
(917) 806-4057Website
www.calderbiosciences.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Calder Biosciences
Calder Biosciences Inc. is a nano-scale molecular engineering company focused on developing conformationally stabilized subunit vaccines to protect against RSV, seasonal and pandemic influenza, and other viral infections. Utilizing their proprietary 3D-Vaxlock technology, they create vaccines that elicit strong immune responses by locking immunogens in their most effective 3D shapes. The company aims to address global health issues with safe, effective, and durable vaccines while minimizing clinical risks. Their target clients include healthcare providers and organizations seeking innovative solutions to combat viral infections.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Calder Biosciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Calder Biosciences, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Calder Biosciences has new funding data
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Calder Biosciences launches new products
Check if Calder Biosciences has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Calder Biosciences recently announced quarterly report
Click to see if Calder Biosciences had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Calder Biosciences
Check out if Calder Biosciences is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Calder Biosciences
Compare insights from companies similar to Calder Biosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Calder Biosciences
<$5M
11-50
Private
-
2018
N/A
Company Profile Activity
Activity Insights
Calder Biosciences is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Calder Biosciences is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Calder Biosciences.
Calder Biosciences Tech Stack
A closer look at the technologies used by Calder Biosciences
See more technologies
Calder Biosciences News & Media
Calder Biosciences announces clinical supply agreement with Biodextris to evaluate its lead RSV vaccine candidate as part of a Phase 1 clinical trial
2023 BIO International Convention BOSTON, June 6, 2023 /PRNewswire/ - Calder Biosciences Inc., a molecular engineering and clinical manufacturing-stage biotechnology company pioneering its 3D-Vaxlockä platform technology to engineer and develop novel protein subunit vaccines, today...
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Calder Biosciences
Sign Up For FreeTo access detailed company insights
Calder Biosciences Inc. is a nano-scale molecular engineering company focused on developing conformationally stabilized subunit vaccines to protect against RSV, seasonal and pandemic influenza, and other viral infections. Utilizing their proprietary 3D-Vaxlock technology, they create vaccines that elicit strong immune responses by locking immunogen... Read More
